HIGHLIGHTS
- who: J. Clin. Med. and colleagues from the Department Neurology, Taiwan University Hospital, College Medicine, Taiwan have published the Article: Clinical Medicine, in the Journal: (JOURNAL)
- what: The authors aimed to examine whether Ser129-phosphorylated marker PD progression. In this longitudinal follow-up study, the authors aimed to examine whether plasma levels of pS129-u03b1-synuclein are associated with motor and cognitive progression in PD. This study had a prospective and longitudinal follow-up design. Because the biomarker data compared in different groups in this study did not follow a Gaussian distribution and violated the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.